ArticleOncotarget2017

Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial.

Mel S Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.